Cardionomic reports the successful completion of its equity issuance

XDATA – October 16th 2015
Cardionomic placed $21.83 million worth of securities as part of a non-brokered equity financing round. The placement, which started on October 2nd, lured a total of twelve subscribers. No offering was previously initiated by the company under a registration exemption with the SEC.
Cardionomic develops a neuromodulation therapy for heart failure. The company spun off from Denali Medical II, a New Enterprise Associates (NEA) backed incubator, it is funded by NEA, Greatbatch Medical and Cleveland Clinic Foundation.
The company, headquartered in Forest Lake MN, is led by Steve Goedeke (President and CEO). Cardionomic elected to keep its revenues undisclosed.
The board of directors includes Ali Behbahani, Dan Kaiser, Jay Graf, Karen Shanahan, Michael Demane and William Abraham.
Offering recap
Status: Completed
Company: Cardionomic
Industry: Other Health Care
Amount offered: $21.83 million
Amount placed: $21.83 million
SEC filing: Source
First sale: 10-02-2015
Data as of: 10-16-2015


Hey if you didn’t know about it, maybe it is time to add XDATA as part of your market monitoring regimen, 14 days free trials are available¬†here.

For more information visit


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s